In our previous study, we showed that PI3K inhibitors block cell proliferation of breast cancer cells overexpressing AKR1B10, which suggested that AKR1B10 may regulate the AKT signaling pathway in breast cancer. The gene discussed is AKR1B10; the disease is breast cancer.